I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Noriyuki Okonogi
52
results:
OpenAccess-fulltext X
Search for persons
X
Sorted by: Year
Sorted by: Relevance
?
1
Identification of Early Biochemical Recurrence Predictors i..:
Takanobu Utsumi
;
Hiroyoshi Suzuki
;
Hitoshi Ishikawa
...
https://www.mdpi.com/1718-7729/30/10/636. , 2023
Link:
https://doi.org/10.3390/..
?
2
A Phase Ib Study of Durvalumab (MEDI4736) in Combination wi..:
Okonogi, Noriyuki
;
Murata, Kazutoshi
;
Yamada, Shigeru
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342070/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
3
The clinical relative biological effectiveness and prostate..:
Yu‐Mei Kang
;
Hitoshi Ishikawa
;
Taku Inaniwa
...
https://doi.org/10.1002/cam4.5045. , 2023
Link:
https://doi.org/10.1002/..
?
4
A Phase Ib Study of Durvalumab (MEDI4736) in Combination wi..:
Noriyuki Okonogi
;
Kazutoshi Murata
;
Shigeru Yamada
...
Molecular Oncology. , 2023
Link:
https://doi.org/10.3390/..
?
5
A Phase Ib Study of Durvalumab (MEDI4736) in Combination wi..:
Noriyuki Okonogi
;
Kazutoshi Murata
;
Shigeru Yamada
...
https://www.mdpi.com/1422-0067/24/13/10565. , 2023
Link:
https://doi.org/10.3390/..
?
6
Clinical advantage and outcomes of computed tomography‐base..:
Noriyuki Okonogi
;
Kazutoshi Murata
;
Toshiaki Matsui
...
https://doi.org/10.1002/cnr2.1607. , 2022
Link:
https://doi.org/10.1002/..
?
7
Phase Ib study of durvalumab (MEDI4736) in combination with..:
Okonogi, Noriyuki
;
Usui, Hirokazu
;
Murata, Kazutoshi
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896055/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
8
Secondary cancers after carbon‐ion radiotherapy and photon ..:
Nitta, Yuki
;
Murata, Hiroto
;
Okonogi, Noriyuki
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189463/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
9
Secondary cancers after carbon‐ion radiotherapy and photon ..:
Yuki Nitta
;
Hiroto Murata
;
Noriyuki Okonogi
...
https://doi.org/10.1002/cam4.4622. , 2022
Link:
https://doi.org/10.1002/..
?
10
An Asian multi-national, multi-institutional, retrospective..:
Noriyuki Okonogi
;
Naoya Murakami
;
Ken Ando
...
https://www.termedia.pl/An-Asian-multi-national-multi-institutional-retrospective-study-on-image-guided-brachytherapy-in-cervical-adenocarcinoma-and-adenosquamous-carcinoma,54,47785,1,1.html. , 2022
Link:
https://doi.org/10.5114/..
?
11
Risk of secondary malignancy after radiotherapy for breast ..:
Okonogi, Noriyuki
;
Karasawa, Kumiko
;
Nitta, Yuki
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287211/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
12
Clinical advantage and outcomes of computed tomography‐base..:
Okonogi, Noriyuki
;
Murata, Kazutoshi
;
Matsui, Toshiaki
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675380/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
13
An Asian multi-national, multi-institutional, retrospective..:
Okonogi, Noriyuki
;
Murakami, Naoya
;
Ando, Ken
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528827/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
14
The clinical relative biological effectiveness and prostate..:
Kang, Yu‐Mei
;
Ishikawa, Hitoshi
;
Inaniwa, Taku
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883571/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
15
PARP Inhibitors in Combination with Radiotherapy: To Do or ..:
Amelia Barcellini
;
Pierre Loap
;
Kazutoshi Murata
...
https://www.mdpi.com/2072-6694/13/21/5380. , 2021
Link:
https://doi.org/10.3390/..
1-15